AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$BCBP

Kim Denny purchased $501 of BCBP

Kim Denny purchased 57 shares of BCB BANCORP INC (BCBP) at $8.78 on 2026-11-03.

Original reporting
SEC EDGAR · Kim Denny
Published Nov 5, 2026, 3:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 3:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BCBP
Neutral
high confidence
Mentioned
$BCBP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BCBPNeutralLow
01

Why it matters

The purchase is too small to move the stock, but it confirms the director's continued stake.

02

Market read

Limited relevance; serves mainly as a compliance disclosure with negligible trading impact.

03

What to watch

Potential upcoming board actions or strategic moves not reflected in this tiny purchase.

Relevance 4/10Novelty 3/10Timing: today

Background

Form 4 filings disclose insider transactions; this filing reports a modest purchase by a director.

Company-level read

Ticker impact

$BCBPNeutralHigh confidence
Context

Director Kim Denny purchased 57 shares at $8.785 each, total $500.74, disclosed via Form 4 filing.

Expected impact

minimal pressure as market views purchase as routine

Evidence & confidence

The transaction size is trivial relative to market cap and typical daily volume.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

Even small insider buys can signal confidence; some traders may view it as a subtle bullish cue.

Key entities

  • Person
    Kim Denny

    Director of BCB BANCORP INC

  • Company
    BCB BANCORP INC

    US-listed bank holding company

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BCBP insider trading history →

Related articles

$BCBPMed

BCB Bancorp Inc (BCBP) (Q3 2026) Earnings Call Highlights: Classified Loans Slashed 70%

BCB Bancorp (BCBP) reported Q3 2026 earnings, highlighting a 70% reduction in classified loans. CEO Thomas O'Brien discussed recapturing deferred tax assets, expense run rates, and cannabis loan transactions. Criticized loans decreased from $207 million to $153 million. The Business Express loan portfolio showed improved performance. The bank completed a successful capital raise and expects better results in Q4.

finance.yahoo.com
$BCBPMed

BCB Bancorp, Inc. Announces Results for the Third Quarter 2026

BCB BANCORP INC (BCBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 C ONTACT : J AWAD C HAUDHRY , EVP, CFO & T REASURER (201) 823-0700 BCB Bancorp, Inc. Announces Results for the Third Quarter 2026; Achieves Substantial Progress Towards Restructured Balance Sheet. • Successfully completed a $98.0 million equity capital raise through

SEC EDGAR 8-K
$BCBPMed

Piper Sandler cuts BCB Bancorp stock price target after dilutive offering

Piper Sandler reduced its price target on BCB Bancorp (BCBP) to $9.50 from $11.00, maintaining a Neutral rating. The bank raised $98 million via a dilutive offering, resulting in 41% ownership dilution. Piper Sandler described the capital raise as aggressive but necessary. BCBP reported a loss of $1.11 per share over the last twelve months but expects profitability this year. The stock traded 13% above the deal price post-announcement.

investing.com